APA (7th ed.) Citation

Akshay Flora, M., Richard Holland, M., Annika Smith, M., & John W. Frew, M. (2021). Rapid and sustained remission of synovitis, acne, pustulosis, hyperostosis, and osteitis (SAPHO) syndrome with IL-23p19 antagonist (risankizumab). Elsevier.

Chicago Style (17th ed.) Citation

Akshay Flora, MD, MBChB Richard Holland, MBBS Annika Smith, and MBBS John W. Frew. Rapid and Sustained Remission of Synovitis, Acne, Pustulosis, Hyperostosis, and Osteitis (SAPHO) Syndrome with IL-23p19 Antagonist (risankizumab). Elsevier, 2021.

MLA (9th ed.) Citation

Akshay Flora, MD, et al. Rapid and Sustained Remission of Synovitis, Acne, Pustulosis, Hyperostosis, and Osteitis (SAPHO) Syndrome with IL-23p19 Antagonist (risankizumab). Elsevier, 2021.